cgp 42112a has been researched along with acetovanillone in 1 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (acetovanillone) | Trials (acetovanillone) | Recent Studies (post-2010) (acetovanillone) |
---|---|---|---|---|---|
233 | 0 | 35 | 1,029 | 7 | 611 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asghar, M; Hussain, T; Sabuhi, R | 1 |
1 other study(ies) available for cgp 42112a and acetovanillone
Article | Year |
---|---|
Inhibition of NAD(P)H oxidase potentiates AT2 receptor agonist-induced natriuresis in Sprague-Dawley rats.
Topics: Acetophenones; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic GMP; Glomerular Filtration Rate; Homeostasis; Male; NADPH Oxidases; Natriuresis; Nitric Oxide; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium; Tetrazoles | 2010 |